South Korea
Industry
BMI View: Ovarian cancer is not a major health problem in Asia compared with other malignancies. As the region's economies develop over the medium term, the incidence of ovarian cancer...
2010-09-01Industry
One of BMI's short-term core views is that sales forces will contract in developed states and expand in emerging markets. The primary cause of this trend is the declining influence...
2010-04-16Industry
Samsung Electronics has contracted local drugmaker Choongwae to promote its new blood testing machine to hospitals and clinics in South Korea. BMI expects the partnership to be a...
2010-04-14Industry
Japan is no longer the most attractive pharmaceutical market in Asia Pacific, according to BMI's Q310 Pharmaceuticals & Healthcare Business Environment Ratings (BERs) for the region....
2010-04-13Industry
BMI is maintaining its forecast for South Korea's US$10.5bn pharmaceutical market despite changes to the medicine pricing and purchasing regime. The government is planning to reduce...
2010-02-16Industry
The value of South Korea's over-the-counter (OTC) medicine market is expected to increase from KRW2,513bn (US$1.97bn) in 2009 to KRW2,544bn (US$2.42bn) in 2010. Due to the strengthening...
2010-01-28Industry
Healthcare spending in South Korea is expected to increase from KRW75,117bn (US$58.9bn) in 2009 to KRW84,053bn (US$80.1bn) in 2010. Due to the strengthening won, this equates to growth...
2010-01-25Industry
In order to fully penetrate the world's largest medicine market, South Korea's Daewoong Pharmaceutical has established a US unit in the state of Maryland. The new venture will focus...
2010-01-19
